Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 219038, 14 pages
http://dx.doi.org/10.1155/2014/219038
Clinical Study

A New Surgical Technique of Pancreaticoduodenectomy with Splenic Artery Resection for Ductal Adenocarcinoma of the Pancreatic Head and/or Body Invading Splenic Artery: Impact of the Balance between Surgical Radicality and QOL to Avoid Total Pancreatectomy

Department of Hepatobiliary Pancreatic and Transplant Surgery, School of Medicine, Mie University, 2-174 Edobashi, Tsu, Mie 514-0001, Japan

Received 14 March 2014; Accepted 18 April 2014; Published 12 June 2014

Academic Editor: Masahiko Hirota

Copyright © 2014 Ryosuke Desaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Ihse, H. Anderson, A. Sandberg et al., “Total pancreatectomy for cancer of the pancreas: is it appropriate?” World Journal of Surgery, vol. 20, pp. 288–294, 1996. View at Google Scholar
  2. S. Reddy, C. L. Wolfgang, J. L. Cameron et al., “Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term Survival,” Annals of Surgery, vol. 250, no. 2, pp. 282–287, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Barbier, W. Jamal, S. Dokmak et al., “Impact of total pancreatectomy: short- and long-term assessment,” HPB, vol. 15, no. 1, pp. 882–892, 2013. View at Publisher · View at Google Scholar
  4. T. Okabayashi, I. Nishimori, K. Yamashita et al., “Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial,” Archives of Surgery, vol. 144, no. 10, pp. 933–937, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. D. G. Heidt, C. Burant, and D. M. Simeone, “Total pancreatectomy: indications, operative technique, and postoperative sequelae,” Journal of Gastrointestinal Surgery, vol. 11, no. 2, pp. 209–216, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Mizuno, S. Isaji, I. Ohsawa et al., “Pancreaticoduodenectomy with resection of the splenic artery and splenectomy for pancreatic double cancers after total gastrectomy. Preservation of the pancreatic function via the blood supply from the posterior epiploic artery: report of a case,” Surgery Today, vol. 42, pp. 482–488, 2012. View at Google Scholar
  7. J. G. Fortner, “Surgical principles for pancreatic cancer: regional total and subtotal pancreatectomy,” Cancer, vol. 47, no. 6, pp. 1712–1718, 1981. View at Google Scholar · View at Scopus
  8. J. Permert, I. Ihse, L. Jorfeldt, H. Von Schenck, H. J. Arnquist, and J. Larsson, “Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer,” British Journal of Surgery, vol. 80, no. 8, pp. 1047–1050, 1993. View at Google Scholar · View at Scopus
  9. D. E. R. Sutherland, F. C. Goetz, and J. S. Najarian, “Living-related donor segmental pancreatectomy for transplantation,” Transplantation Proceedings, vol. 12, no. 4, pp. 19–25, 1980. View at Google Scholar · View at Scopus
  10. A. L. Warshaw, “Conservation of the spleen with distal pancreatectomy,” Archives of Surgery, vol. 123, no. 5, pp. 550–553, 1988. View at Google Scholar · View at Scopus
  11. Y. Murata, T. Hamada, M. Kishiwada et al., “Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy,” Journal of Hepato-Biliary-Pancreatic Sciences, vol. 19, pp. 413–425, 2012. View at Google Scholar
  12. M. Kobayashi, S. Mizuno, Y. Murata et al., “Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter-1 expression,” Pancreas, vol. 43, no. 3, pp. 350–360, 2014. View at Publisher · View at Google Scholar
  13. S. Isaji, M. Usui, H. Sakurai et al., “Antegrade proximal pancreatectomy for lower bile duct adenocaricinoma and ampulla of Vater carcinoma,” Operation, vol. 61, pp. 821–827, 2007 (Japanese). View at Google Scholar
  14. S. Mizuno, S. Isaji, A. Tanemura et al., “Anterior approach to the superior mesenteric artery by using nerve plexus hanging maneuver for borderline resectable pancreatic head carcinoma,” Journal of Gastrointestinal Surgery, 2014. View at Publisher · View at Google Scholar
  15. S. M. Strasberg, J. A. Drebin, and D. Linehan, “Radical antegrade modular pancreatosplenectomy,” Surgery, vol. 133, no. 5, pp. 521–527, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Hirota, S. Shimada, K. Yamamoto et al., “Pancreatectomy using the no-touch isolation technique followed by extensive intraoperative peritoneal lavage to prevent cancer cell dissemination: a pilot study,” Journal of the Pancreas, vol. 6, no. 2, pp. 143–151, 2005. View at Google Scholar · View at Scopus
  17. Y. Azumi, S. Isaji, H. Kato et al., “standardized technique for safe pancreaticojejunostomy: pair-Watch suturing technique,” World Journal of Gastrointestinal Surgery, vol. 2, pp. 260–264, 2010. View at Google Scholar
  18. National Comprehensive Cancer Network Practice Guidelines in Oncology (NCCN Guidelines). Pancreas Adenocarcinoma. Version 1, 2010, http://www.nccn.org/.
  19. D. Dindo, N. Demartines, and P.-A. Clavien, “Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey,” Annals of Surgery, vol. 240, no. 2, pp. 205–213, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. Classification of Pancreatic Carcinoma, Japan Pancreatic Society, Kanehara & Co., Led, Tokyo, Japan, 2009.
  21. D. B. Evans, T. A. Rich, D. R. Byrd et al., “Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas,” Archives of Surgery, vol. 127, no. 11, pp. 1335–1339, 1992. View at Google Scholar · View at Scopus
  22. M. R. Hayden, K. Patel, J. Habibi et al., “Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities,” Journal of the cardiometabolic syndrome, vol. 3, no. 4, pp. 234–243, 2008. View at Google Scholar · View at Scopus
  23. B. Lindkvist, J. E. Domínguez-Muñoz, M. Luaces-Regueira et al., “Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis,” Pancreatology, vol. 12, pp. 305–310, 2012. View at Google Scholar
  24. R. Yadav, J. P. Bhartiya, S. K. Verma et al., “The evaluation of serum amylase in the patients of type 2 diabetes mellitus, with a possible correlation with the pancreatic functions,” Journal of Clinical and Diagnostic Research, vol. 7, pp. 1291–1294, 2013. View at Google Scholar
  25. M. Small, H. N. Cohen, G. H. Beastall, and A. C. MacCuish, “Comparison of oral glucose loading and intravenous glucagon injection as stimuli to C-peptide secretion in normal men,” Diabetic Medicine, vol. 2, no. 3, pp. 181–183, 1985. View at Google Scholar · View at Scopus
  26. S. Hirano, S. Kondo, T. Hara et al., “Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results,” Annals of Surgery, vol. 246, no. 1, pp. 46–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Unno, M. Suzuki, N. Yamamoto et al., “Indocyanine Green Fluorescence Angiography for Intraoperative Assessment of Blood Flow: a Feasibility Study,” European Journal of Vascular and Endovascular Surgery, vol. 35, no. 2, pp. 205–207, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Mochizuki, T. Gabata, K. Kozaka et al., “MDCT findings of extrapancreatic nerve plexus invasion by pancreas head carcinoma: Correlation with en bloc pathological specimens and diagnostic accuracy,” European Radiology, vol. 20, no. 7, pp. 1757–1767, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. C. M. Schmidt, J. Glant, J. M. Winter et al., “Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma,” Surgery, vol. 142, no. 4, pp. 572–580, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Y. Jang, S. W. Kim, J. K. Han et al., “Randomized prospective trial of the effect of induced hypergastrinemia on the prevention of pancreatic atrophy after pancreatoduodenectomy in humans,” Annals of Surgery, vol. 237, no. 4, pp. 522–529, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Kirihara, N. Takahashi, Y. Hashimoto et al., “Prediction of pancreatic anastomotic failure after pancreatoduodenectomy: the use of preoperative, quantitative computed tomography to measure remnant pancreatic volume and body composition,” Annals of Surgery, vol. 257, pp. 512–519, 2013. View at Google Scholar
  32. R. Sato, M. Kishiwada, N. Kuriyama et al., “Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreatico-duodenectomy,” Journal of Hepato-Biliary-Pancreatic Sciences. In press.
  33. M. Dorlon, S. Owczarski, H. Wang et al., “Increase in postoperative insulin requirements does not lead to decreased quality of life after total pancreatectomy with islet cell autotransplantation for chronic pancreatitis,” The American Surgeon, vol. 79, no. 7, pp. 676–680, 2013. View at Google Scholar
  34. X. Liu, S. Förster, U. Adam, W. Schmidt, P. Müller, and U. T. Hopt, “Islet autotransplantation combined with total pancreatectomy for treatment of pancreatic adenocarcinoma,” Transplantation Proceedings, vol. 33, no. 1-2, pp. 662–663, 2001. View at Publisher · View at Google Scholar · View at Scopus